Demonstrates enhanced oxidase-like activity in nanozymes, suggesting improved catalytic performance in biomedical applications.
By replacing the linear terephthalate linker with five-membered heterocyclic analogues, we synthesized a series of MIL-53(Fe) nanozymes. The incorporated heteroatoms (O or S) effectively modulate the electron density of the metal active sites. Consequently, the MIL-53(Fe)-TDC variant exhibits an approximately six-fold enhancement in oxidase-like activity compared to its counterpart MIL-53(Fe)-BDC.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: